Multiple 'Targeted' Drugs Quell Brain Tumors
Dana-Farber Cancer InstituteResearchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.